SYNERGEYES HYBRID CONTACT LENS DUH300 NA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2014-01-22 for SYNERGEYES HYBRID CONTACT LENS DUH300 NA manufactured by Synergeyes, Inc..

Event Text Entries

[4091184] Synergeyes determined within 30 days of receipt of the complaint that the event was not reportable. This decision was based on the information provided to synergeyes on (b)(6) 2013, wherein the patient experienced irritation, photophobia, watery eyes, and corneal abrasion/cell plus flare during the fitting process. These symptoms indicated that there was a fitting/non-adaptation issue and that the physician should have either tried a steeper diagnostic lens or discontinued attempting to fit a postsurgical eye with an ultrahealth lens. On (b)(6) synergeyes received information from the physician that the patient "had full-blown iritis, wit cells and flare. " receipt of this information changed the status of not reportable to reportable. Comments from discussion w/doctor on (b)(6) 2014: patient is post-rk in left eye and post-corneal graft in right eye. The doctor acknowledged that the ultrahealth lens is not indicated for postsurgical, but wanted to try it anyway.
Patient Sequence No: 1, Text Type: D, B5


[11490874] On (b)(6)2013, the doctor fit an ultrahealth 300 vault diagnostic lens on the patient's right eye. Immediately the patient stated that the lens felt uncomfortable, but "not bad. " the right eye was watering. The lens was removed and the eye rinsed with saline. The doctor inserted an ultrahealth 350 vault diagnostic lens. The patient had the same response and exhibited mild spk, but not bad. The patient was willing to go home with lens. The patient returned the next day ((b)(6) 2013) with an irritated right eye and was photophobic. The doctor noted the iritis, with cells and flare, removed lens, and started durezol (steroid) and besivance (antibiotic). The patient returned on (b)(6) 2013 and it was noted that the patient's eye looked better with little straining and reduced iritis. The doctor suggested tapering the med regimen with the patient to return later. When patient was contacted a few days later ((b)(6) 2013) she declined further follow-up and stated that her eye was fine. On (b)(6) 2013, the patient returned to the doctor wearing her previous (non-ultrahealth) contact lens for her right eye. The patient's vision was good and the iritis, with cells and flare was completely healed. The doctor reported no further plans to fit the patient's right eye with an ultrahealth lens. Synergyes reminded the doctor that the ultrahealth lens is not indicated for postsurgical eyes.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005087645-2014-00003
MDR Report Key3597077
Report Source05
Date Received2014-01-22
Date of Report2014-01-21
Date of Event2013-12-02
Date Mfgr Received2013-12-03
Device Manufacturer Date2013-05-01
Date Added to Maude2014-01-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactKAREN KINCADE, DIR
Manufacturer Street2232 RUTHERFORD ROAD
Manufacturer CityCARLSBAD CA 92008
Manufacturer CountryUS
Manufacturer Postal92008
Manufacturer Phone7604449636
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSYNERGEYES HYBRID CONTACT LENS
Generic NameCONTACT LENS
Product CodeHQD
Date Received2014-01-22
Model NumberDUH300
Catalog NumberNA
Lot Number051160-1
ID NumberNA
Device Expiration Date2013-06-01
OperatorLAY USER/PATIENT
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSYNERGEYES, INC.
Manufacturer AddressCARLSBAD CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2014-01-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.